Trial Court Dismissal of Zofran Birth Defect Lawsuits Upheld on Appeal Before First Circuit
The 2021 decision to dismiss all Zofran birth defect lawsuits was upheld, after the appeals court affirmed the FDA would not have let GlaxoSmithKline change the label warnings even if it had wanted to do so.